Thymic Atrophy and Immune Dysregulation in Infants with Complex Congenital Heart Disease

Sarah-Jolan Bremer,Annika Boxnick,Laura Glau,Daniel Biermann,Simon A Joosse,Friederike Thiele,Elena Billeb,Jonathan May,Manuela Kolster,Romy Hackbusch,Mats Ingmar Fortmann,Rainer Kozlik-Feldmann,Michael Hübler,Eva Tolosa,Jörg Siegmar Sachweh,Anna Gieras,Simon A. Joosse

DOI: https://doi.org/10.1007/s10875-024-01662-4

IF: 8.542

2024-02-24

Journal of Clinical Immunology

Abstract:Congenital heart disease (CHD) is the most common birth defect, and up to 50% of infants with CHD require cardiovascular surgery early in life. Current clinical practice often involves thymus resection during cardiac surgery, detrimentally affecting T-cell immunity. However, epidemiological data indicate that CHD patients face an elevated risk for infections and immune-mediated diseases, independent of thymectomy. Hence, we examined whether the cardiac defect impacts thymus function in individuals with CHD. We investigated thymocyte development in 58 infants categorized by CHD complexity. To assess the relationship between CHD complexity and thymic function, we analyzed T-cell development, thymic output, and biomarkers linked to cardiac defects, stress, or inflammation. Patients with highly complex CHD exhibit thymic atrophy, resulting in low frequencies of recent thymic emigrants in peripheral blood, even prior to thymectomy. Elevated plasma cortisol levels were detected in all CHD patients, while high NT-proBNP and IL-6 levels were associated with thymic atrophy. Our findings reveal an association between complex CHD and thymic atrophy, resulting in reduced thymic output. Consequently, thymus preservation during cardiovascular surgery could significantly enhance immune function and the long-term health of CHD patients.

immunology

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to explore the impact of congenital heart disease (CHD) on thymus function, especially whether complex CHD will lead to thymus atrophy, thereby affecting the development and export of T - cells. The research background indicates that approximately 50% of CHD infants need to undergo heart surgery in the early stage of life, and these surgeries usually involve thymectomy, which has a negative impact on T - cell immune function. However, even without thymectomy, CHD patients still face a relatively high risk of infection and immune - mediated diseases. Therefore, researchers want to explore whether the heart defect itself will affect the function of the thymus.

Specifically, the paper evaluated the development of T - cells, thymus output, and biomarkers related to heart defects, stress or inflammation by analyzing the thymocyte development of 58 infants with different degrees of complexity of CHD. The study found that patients with highly complex CHD showed thymus atrophy, resulting in a lower proportion of recent thymic emigrants (RTE) in peripheral blood, which had already occurred before thymectomy. In addition, the plasma cortisol levels of all CHD patients were elevated, and high levels of NT - proBNP and IL - 6 were associated with thymus atrophy. These findings revealed the association between complex CHD and thymus atrophy, leading to a decrease in thymus output. Therefore, the study suggests that preserving the thymus during cardiovascular surgery may significantly improve the immune function and long - term health of CHD patients.